Market
Overview:
Blood coagulant aids in improving
the coagulation process of blood in order to stop bleeding and fastening the
healing process. According to the report that has been published by Market
Research Future (MRFR), blood
coagulants market trends is expected to
reach USD 2.57 billion by 2030 at CAGR 10.90% during the forecast period
2022-2030
Competitive
Landscape:
Increasing demand for high-quality blood coagulants in the market has
led to the introduction of innovative products by the in the Middle East and
Africa blood coagulants market players. The players are focusing on business
expansion by increasing their research and development expenditure and
strategizing mergers and acquisitions for
establishing their products not on in the Middle East and Africa region
but also on a global level.
In February 2018, it was announced
that an Israeli-developed bandage named WoundClot, a plant-based gauze that
stops blood loss within seconds by stimulating body’s coagulation process, will
be sold globally.
The prominent players that are
profiled in the report on the Middle East and Africa market by
MRFR are Pfizer
Inc. (the U.S.), Bayer AG (Germany), Novo Nordisk AS (Denmark), Shire (Republic of Ireland), SOBI (Sweden), Octapharma
(Switzerland), and CSL Limited (Australia). Are Blood coagulants market players
Market
Segmentation:
The Middle East and
Africa blood
coagulants market research is segmented on the basis of types, indications, and by country.
Based on types, the blood coagulants market is segmented into coagulation
factor and others. Coagulation factor segment is sub-segmented into recombinant
coagulation factor, plasma coagulation factor, and others.
Based on indication, the blood coagulants market is segmented into hemophilia, surgery, other bleeding
disorders, and others. Hemophilia segment
is sub-segmented into hemophilia A and hemophilia B.
Market
Drivers and Restraints:
Increasing prevalence of bleeding
disorders caused by diseases such as hemophilia which leads to defect in blood
coagulation is inducing demand for blood coagulants in the market in the Middle East and Africa region.
The beneficial properties of blood coagulant drugs or anti-inhibitor coagulant
complexes to help regulate blood coagulation for patients suffering from
bleeding disorders are fueling the growth of the Middle East and Africa blood
coagulants market.
Rise in incidences of major
injuries caused due to accidents leading to uncontrollable bleeding and
increasing demand for blood thickening medications are likely to propel the
growth of the blood coagulants market in the
Middle East and Africa region during the forecast period. However, lack
of primary health care services, poor
healthcare infrastructure and lack of awareness in the underdeveloped areas are
acting as major restraints on the growth of the Middle East and Africa blood
coagulation market overview during the forecast period.
Regional
Analysis:
The Middle East and
Africa blood coagulants market is geographically segmented into few major countries such as Saudi
Arabia (KSA), United Arab Emirates (UAE), Qatar, Oman, Kuwait, Egypt, and the
rest of the Middle East and Africa.
Saudi Arabia accounts for the
largest share in the Middle East and Africa blood coagulant market. The high
prevalence of hemophilia, increasing usage of expensive recombinant coagulation
factors and high disposable income of the population,
are some of the major factors that are driving the growth of the blood
coagulant market in this country. Whereas, United Arab Emirates (UAE) is
projecting fastest growth in the Middle East and Africa blood coagulants
market.
Increasing
healthcare expenditure and research and development in the field of anti-inhibitor coagulant
complexes are leading to the expansion of the blood coagulants market in the
Middle East and Africa region.
About US:
Market Research Future
(MRFR) enable customers to unravel the complexity of various industries through
Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting
Services.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th
Floor, New York,
New York 10013
